查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1159220

經皮吸收貼片的全球市場(2022年～2028年)

Transdermal Patches Market 2022-2028
出版日期: | 出版商: Orion Market Research | 英文 130 Pages | 商品交期: 2-3個工作天內

價格

全球經皮吸收貼片的市場規模在預測期間內預計將以相當的年複合成長率成長。透皮給藥系統的技術進步和產品創新等各種戰略的採用、增加產品發布和批准以及增加研發投資以促進透皮貼劑的進步，都有助於市場增長。

本報告提供全球經皮吸收貼片市場相關調查分析，提供市場趨勢，市場區隔分析，地區分析，企業簡介等資訊。

目錄

第1章 報告摘要

第2章 市場概要與考察

  • 調查範圍
  • 分析師的考察和目前市場趨勢

第3章 競爭情形

  • 主要企業的分析
    • 3M
    • Aveva
    • Fierce Pharma
    • Novartis AG
    • Teva Pharmaceutical Industries Ltd.
  • 主要策略的分析
  • COVID-19對主要企業的影響

第4章 市場區隔

  • 全球經皮吸收貼片市場:各類型
    • 單層DIA(藥物黏劑)
    • 多層DIA(藥物黏劑)
    • 矩陣
  • 全球經皮吸收貼片市場:各用途
    • 止痛
    • 戒煙·減少煙支援
    • 膀胱過動症
    • 荷爾蒙療法

第5章 地區的分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他的歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他的亞太地區
  • 其他地區

第6章 企業簡介

  • Acrux Limited
  • Agile Therapeutics Inc.
  • Cipla Inc.
  • Glenmark
  • ImQuest Biosciences
  • Luye Pharma Group
  • Mylan N.V.
  • Purdue Pharma L.P.
  • Rusan Pharma
  • Teikoku Pharma USA, Inc.
Product Code: OMR2026314

Global Transdermal Patches Market Size, Share & Trends Analysis Report, By Type (Single-Layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive and Matrix), By Application (Pain Relief, Smoking Reduction and Cessation Aid, Overactive Bladder, and Hormonal Therapy), Forecast Period (2022-2028)

The global transdermal patches market is anticipated to grow at a substantial CAGR during the forecast period. Rising technological advancements in transdermal drug delivery systems, as well as increasing adoption of various strategies such as product innovation, increasing product launches and approvals, rising research and development investment for advancements in transdermal patches, are all contributing to market growth. Furthermore, during the forecast period, rising self-administration and home care drug delivery systems will generate lucrative growth opportunities for the global transdermal patches market.

The global transdermal patches market is segmented based on type and application. Based on the type, the market is sub-segmented into the single-layer drug-in-adhesive, multi-layer drug-in-adhesive and matrix. Based on the application, the market is sub-segmented into pain relief, smoking reduction and cessation aid, overactive bladder and hormonal therapy. Among these, hormonal therapy is propelling the growth of the market. The most common form of transdermal HT has always been patching formulations. As a result, due to the rising number of cases of hormonal issues, the market for transdermal patches is expected to grow. For instance, according to a New York Post in February 2019, A hormonal imbalance has affected nearly half of all women. In hormonal therapy, an estrogen patch (oestrogen patch) is a transdermal delivery device for estrogens such as estradiol and ethinylestradiol that can be used for menopausal hormone therapy, transgender feminizing hormone therapy, hormonal birth control, and other purposes.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America holds the second-largest share in the market after the Asia Pacific. The presence of significant players and established healthcare infrastructure is projected to boost growth. For instance, in April 2021, BASF introduced 'Sacred Patch,' a new skincare active ingredient that promotes emotional well-being. Furthermore, the market is predicted to rise as a result of beneficial government efforts and an increase in the number of research partnerships.

The major companies serving the global transdermal patches market include Novartis AG, Fierce Pharma, 3M, Aveva, Teva Pharmaceutical Industries Ltd., among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2021, Luye Pharma announced that it has received approval for Rivastigmine Multi-Day Transdermal Patch by the UK's Medicines and Healthcare Products Regulatory Agency. It is used for the treatment of mild to moderate dementia associated with Alzheimer's disease.

Research Methodology

The market study of the global transdermal patches market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Transdermal Patches Market Research and Analysis by Type.

2. Global Transdermal Patches Market Research and Analysis by Application.

The Report Covers:

  • Comprehensive Research Methodology of the global transdermal patches market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global transdermal patches market.
  • Insights about market determinants that are stimulating the global transdermal patches market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Transdermal Patches Market
  • Recovery Scenario of Global Transdermal Patches Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. 3M
      • 3.1.1.1. Overview
      • 3.1.1.2. Financial Analysis
      • 3.1.1.3. SWOT Analysis
      • 3.1.1.4. Recent Developments
    • 3.1.2. Aveva
      • 3.1.2.1. Overview
      • 3.1.2.2. Financial Analysis
      • 3.1.2.3. SWOT Analysis
      • 3.1.2.4. Recent Developments
    • 3.1.3. Fierce Pharma
      • 3.1.3.1. Overview
      • 3.1.3.2. Financial Analysis
      • 3.1.3.3. SWOT Analysis
      • 3.1.3.4. Recent Developments
    • 3.1.4. Novartis AG
      • 3.1.4.1. Overview
      • 3.1.4.2. Financial Analysis
      • 3.1.4.3. SWOT Analysis
      • 3.1.4.4. Recent Developments
    • 3.1.5. Teva Pharmaceutical Industries Ltd.
      • 3.1.5.1. Overview
      • 3.1.5.2. Financial Analysis
      • 3.1.5.3. SWOT Analysis
      • 3.1.5.4. Recent Developments
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of COVID-19 on Key Players

4. Market Segmentation

  • 4.1. Global Transdermal patches Market by Type
    • 4.1.1. Single-layer Drug-in-Adhesive
    • 4.1.2. Multi-layer Drug-in-Adhesive
    • 4.1.3. Matrix
  • 4.2. Global Transdermal patches Market by Application
    • 4.2.1. Pain Relief
    • 4.2.2. Smoking Reduction and Cessation Aid
    • 4.2.3. Overactive Bladder
    • 4.2.4. Hormonal Therapy

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. US
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Acrux Limited
  • 6.2. Agile Therapeutics Inc.
  • 6.3. Cipla Inc.
  • 6.4. Glenmark
  • 6.5. ImQuest Biosciences
  • 6.6. Luye Pharma Group
  • 6.7. Mylan N.V.
  • 6.8. Purdue Pharma L.P.
  • 6.9. Rusan Pharma
  • 6.10. Teikoku Pharma USA, Inc.

LIST OF TABLES

  • 1. GLOBAL TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 2. GLOBAL SINGLE-LAYER DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL MULTI-LAYER DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL MATRIX TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 6. GLOBAL PAIN RELIEF TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 7. GLOBAL SMOKING REDUCTION AND CESSATION AID TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 8. GLOBAL OVERACTIVE BLADDER TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. GLOBAL HORMONAL THERAPY TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
  • 11. NORTH AMERICAN TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 12. NORTH AMERICAN TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 13. NORTH AMERICAN TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 14. EUROPEAN TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 15. EUROPEAN TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 16. EUROPEAN TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 17. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 18. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 19. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 20. REST OF THE WORLD TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 21. REST OF THE WORLD TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 22. REST OF THE WORLD TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)

 

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL TRANSDERMAL PATCHES MARKET, 2021-2028 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL TRANSDERMAL PATCHES MARKET BY SEGMENT, 2021-2028 ($ MILLION)
  • 3. RECOVERY OF GLOBAL TRANSDERMAL PATCHES MARKET, 2022-2028 (%)
  • 4. GLOBAL TRANSDERMAL PATCHES MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 5. GLOBAL SINGLE-LAYER DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 6. GLOBAL MULTI-LAYER DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 7. GLOBAL TRANSDERMAL PATCHES MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
  • 8. GLOBAL PAIN RELIEF TRANSDERMAL PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 9. GLOBAL SMOKING REDUCTION AND CESSATION AID TRANSDERMAL PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 10. GLOBAL OVERACTIVE BLADDER TRANSDERMAL PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 11. GLOBAL HORMONAL THERAPY TRANSDERMAL PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 12. GLOBAL TRANSDERMAL PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 13. US TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 14. CANADA TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 15. UK TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 16. FRANCE TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 17. GERMANY TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 18. ITALY TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 19. SPAIN TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 20. REST OF EUROPE TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. INDIA TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. CHINA TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. JAPAN TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 24. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. REST OF ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. REST OF THE WORLD TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)